2021
DOI: 10.3390/ijms22189791
|View full text |Cite
|
Sign up to set email alerts
|

The Adaptive Immune Landscape of the Colorectal Adenoma–Carcinoma Sequence

Abstract: Background. The tumor immune microenvironment exerts a pivotal influence in tumor initiation and progression. The aim of this study was to analyze the immune context of sporadic and familial adenomatous polyposis (FAP) lesions along the colorectal adenoma–carcinoma sequence (ACS). Methods. We analyzed immune cell counts (CD3+, CD4+, CD8+, Foxp3+, and CD57+), tumor mutation burden (TMB), MHC-I expression and PD-L1 expression of 59 FAP and 74 sporadic colorectal lesions, encompassing adenomas with low-grade dysp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 34 publications
(48 reference statements)
0
4
0
Order By: Relevance
“…Involvement of lymphoid cells in CRC stroma, however, is not in general agreement in the research frontier. Using flow cytometry for a comprehensive analysis of immune cells in tumor tissues from a cohort of 69 CRC patients, Li et al claimed that no significant difference was found for the CD4+ and CD8+ T cells between tumor and normal tissues (46), while Freitas et al examined the immune context of sporadic and familial adenomatous polyposis lesions along the colorectal adenomacarcinoma sequence and observed an overall decrease in tumorinfiltrating immune cells along the colorectal tumors (23). During CRC development, immunoediting leads to the generation of plentiful neoantigens presented by both MHC-I and MHC-II that basically require synergetic effects of CD4+ and CD8+ T cells.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Involvement of lymphoid cells in CRC stroma, however, is not in general agreement in the research frontier. Using flow cytometry for a comprehensive analysis of immune cells in tumor tissues from a cohort of 69 CRC patients, Li et al claimed that no significant difference was found for the CD4+ and CD8+ T cells between tumor and normal tissues (46), while Freitas et al examined the immune context of sporadic and familial adenomatous polyposis lesions along the colorectal adenomacarcinoma sequence and observed an overall decrease in tumorinfiltrating immune cells along the colorectal tumors (23). During CRC development, immunoediting leads to the generation of plentiful neoantigens presented by both MHC-I and MHC-II that basically require synergetic effects of CD4+ and CD8+ T cells.…”
Section: Discussionmentioning
confidence: 99%
“…Very recently, Wang et al took a digital spatial profiler, a high-plex spatial proteogenomic technology, to analyze 40 antibodies with DNA oligomer conjugation and a panel of probes for 84 mRNAs related with epithelial and immune cells, and concluded that these specific biomarkers were differentially expressed between the tumor and stromal regions at either the transcriptional or translational levels (22). Freitas et al analyzed the immune landscape of the colorectal adenomatous polyps using IHC and found that compared with low-grade dysplasia, high-grade dysplasia was characterized with decreased immune infiltration, increased MHC-I expression, and lower PD-L1 expression (23). With respect to profiling proteomics, LCM was a common means to isolate the tumor and adjacent stroma tissues, followed by proteomic analysis to identify the differentially expressed proteins (DEPs) between the tumor and adjacent stroma.…”
Section: Introductionmentioning
confidence: 99%
“… 1 , 2 The etiopathogenesis of most CRCs follows a sequence of events that have been described as the adenoma-carcinoma sequence. 3 , 4 This sequence typically takes more than 10 years to complete in sporadic cancers and can be effectively disrupted via screening. 5 Colonoscopy is considered the most efficacious screening method for reducing CRC incidence and mortality because it allows for the early detection and removal of precancerous polyps and the detection of early-stage CRC.…”
Section: Introductionmentioning
confidence: 99%
“…Although a patient's microbiome consists of bacterial, viral, fungal, and archaeal species from a variety of sites throughout the body, tumoral microbes have recently been associated with both the development of CRC as well as the differential responses to cytotoxic therapies, perhaps in association with their ability to regulate immune infiltrates within tumors [8][9][10][11] and modify chemotherapeutic drugs. For example, Escherichia coli isolates from CRC patients were shown to modify 5-fluoroacyl diminishing toxicity to CRC epithelial cells.…”
mentioning
confidence: 99%